Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 4, 1997, Pages 1206-1210

  Huguenel, Edward D ^a   Cohn, Douglas ^b   Dockum, Deborah P ^b   Greve, Jeffrey M ^b   Fournel, Michael A ^b   Hammond, Lisa ^b   Irwin, Russel ^b   Mahoney, James ^b   McClelland, Alan ^b   Muchmore, Elizabeth ^b   Ohlin, Ann C ^b   Scuderi, Phillip ^b  

^a BAYER CORPORATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; DRUG EFFICACY; INFECTION PREVENTION; INTRANASAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RHINOVIRUS; RNA VIRUS INFECTION; VIRUS SHEDDING;

EID: 8244241096     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.4.9105055     Document Type: Article

References (32)

1. Johnston, S. L., P. G. Bardin, and P. K. Pattemore. 1993. Viruses as precipitants of asthma symptoms III. Rhinoviruses: Molecular biology and prospects for future intervention. Clin. Exp. Allergy 23: 237-246.
2. Pattemore, P. K., S. L. Johnston, and P. G. Bardin. 1992. Viruses as precipitants of asthma symptoms I. Epidemiology. Clin. Exp. Allergy 22:325.
3. Johnston, S. L., P. K. Pattemore, G. Sanderson, S. Smith, F. Lampe, L. Josephs, P. Symington, S. O'Toole, S. H. Myint, D. A. J. Tyrrell, and S. H. Holgate. 1995. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. B.M.J. 310: 1225-1229.
4. Lemanske, R. F., E. C. Dick, C. A. Swenson, R. F. Vrtis, and W. W. Busse. 1989. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthma reactions. J. Clin. Invest. 83:1-10.
5. Halperin, S. A., P. A. Eggleston, P. Beasley, P. Suratt, J. O. Hendley, D. H. M. Groschel, and J. M. Gwaltney, Jr. 1985. Exacerbations of asthma in adults during experimental rhinovirus infection. Am. Rev. Respir. Dis. 132:976.
6. Woods, M. G., G. D. Diana, M. C. Rogge, M. J. Otto, F. J. Dutko, and M. A. McKinlay. 1989. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrob. Agents Chemother. 33:2069-2074.
7. Turner, R. B., F. J. Dutko, N. H. Goldstein, G. Lockwood, and F. G. Hayden. 1993. Efficacy of oral win 54954 for prophylaxis of experimental rhinovirus infection. Antimicrob. Agents Chemother. 37: 297-300.
8. Hayden, F. G., K. Andries, and P. A. J. Janssen. 1992. Safety and efficacy of intranasal Pirodavir (R77975) in experimental rhinovirus infection. Antimicrob. Agents Chemother. 36:727-732.
9. Hayden, F. G., G. J. Hipskind, D. H. Woerner, G. F. Eisen, M. Janssens, P. A. J. Janssen, and K. Andries. 1995. Intranasal Pirodavir (R77,975) treatment of rhinovirus colds. Antimicrob. Agents Chemother. 39:290-294.
10. 2 treatment of experimental rhinoviral colds. J. Infect. Dis. 150: 174-180.
11. Samo, T. C., S. B. Greenberg, J. M. Palmer, R. B. Couch, M. W. Harmon, and P. E. Johnson. 1984. Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose. J. Infect. Dis. 150:181-188.
12. 2-interferon against rhinovirus infections in the family setting. N. Engl. J. Med. 314:65-70.
13. 2-interferon. N. Engl. J. Med. 314:71-75.
14. Greve, J. M., G. Davis, A. M. Meyer, C. P. Forte, S. C. Yost, C. W. Marlor, M. E. Kamarck, and A. McClelland. 1989. The major human rhinovirus receptor is ICAM-1. Cell 56:839-847.
15. Staunton, D. E., V. J. Merluzzi, R. Rothlein, R. Barton, S. Marlin, and T. A. Springer. 1989. A cell adhesion molecule, ICAM-1 is the major surface receptor for rhinoviruses. Cell 56:849-853.
16. Colonno, R. J., P. L. Callahan, and W. J. Long. 1986. Isolation of a monoclonal antibody that blocks attachment of the major group of rhinoviruses. J. Virol. 57:7-12.
17. Hayden, F. G., J. M. Gwaltney, Jr., and R. J. Colonno. 1988. Modification of experimental rhinovirus colds by receptor blockade. Antiviral Res. 9:233-247.
18. Greve, J. M., C. P. Forte, C. W. Marlor, A. M. Meyer, H. Hoover-Litty, D. Wunderlich, and A. McClelland. 1991. Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1. J. Virol. 65:6015-6023.
19. Crump, C. E., E. Arruda, and F. G. Hayden. 1993. In vitro inhibitory activity of soluble ICAM-1 for the numbered serotypes of human rhinovirus. Antiviral Chem. Chemother. 4:323-327.
20. Ohlin, A., H. Hoover-Litty, G. Sanderson, A. Paessens, S. L. Johnston, S. T. Holgate, E. Huguenel, and J. M. Greve. 1994. Spectrum of activity of soluble intercellular adhesion molecule-1 against rhinovirus reference strains and field isolates. Antimicrob. Agents Chemother. 38:1413-1415.
21. Dochez, A. R., G. S. Shibley, and K. C. Mills. 1930. Studies in the common cold. J. Exp. Med. 52:701-716.
22. Dick, E. C. 1968. Experimental infection of chimpanzees with human rhinovirus types 14 and 43. Proc. Soc. Exp. Biol. Med. 127:1079-1081.
23. Dick, E. C., and C. R. Dick. 1968. A subclinical outbreak of human rhinovirus 31 infection in chimpanzees. Am. J. Epidemiol. 88:267-272.
24. Dick, E. C., and C. R. Dick. 1974. Natural and experimental infections of nonhuman primates with respiratory viruses. Lab. Anim. Sci. 24:177-181.
25. Minor, P. D. 1985. In B. W. J. Mahy, editor. Virology: A Practical Approach. IRL Press, Oxford. 28-31.
26. Gwaltney, J. M., Jr., R. J. Colonno, V. V. Hamparian, and R. B. Turner. 1989. Rhinovirus. In N. J. Schmidt and R. W. Evans, editors. Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, 6th ed. American Public Health Association, Washington, DC. 603.
27. Couch, R. B., T. R. Cate, R. C. Douglas, Jr., J. P. Gerone, and V. Knight. 1966. Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission. Bacteriol. Rev. 30:517-529.
28. D'Alessio, D. J., C. K. Meschievitz, J. A. Peterson, C. R. Dick, and E. C. Dick. 1984. Short-duration exposure and the transmission of rhinoviral colds. J. Infect. Dis. 150:189-194.
29. Douglas, R. G. 1970. Pathogenesis of rhinovirus common colds in human volunteers. Ann. Otol. Rhinol. Laryngol. 79:563-571.
30. Hendley, J. O., W. P. Edmundson, Jr., and J. M. Gwaltney, Jr. 1972. Relation between naturally acquired immunity and infectivity of two rhinoviruses in volunteers. J. Infect. Dis. 125:243-248.
31. Illum, L. 1991. The nasal delivery of peptides and proteins. Trends Biotech. 9:284-289.
32. Schipper, N. G. M., J. C. Verhoef, and F. W. H. M. Merkus. 1991. The nasal mucocilliary clearance: relevance to nasal drug delivery. Pharm. Res. 8:807-814.